United States · Platforms & data · Investing.com

BTIG raises Rapport Therapeutics price target to $89 on trial data

Published by Investing.com · United States 3 h ago

Read the full article on Investing.com Sign in to save

MarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.investing.com)

Also worth reading

The Motley Fool

Why Braze Stock Skyrocketed Today

AmeriServ Financial GAAP EPS of $0.18, revenue of $15.96M

Here’s why GM’s stock is having its worst day in over a year

Toncoin (TON) Price Prediction 2025, 2026, 2027-2030

HSBC CEO warns the AI boom won’t make every data center a good bet

BlackRock Files Its Third Bitcoin ETF, A 'Buffer' Fund That Targets Investors Seeking Downside Protection